FOSL2 and glioblastoma: Regarding previously reported glioblastoma mesenchymal signature transcription factors, SOX2 as opposed to SFRP2, decreased CEBPB and FOSL2 levels consistent with their negative correlation to SOX2 in TCGA glioblastomas (Fig. S3A, B).